Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Molecular changes during the genesis of human gliomas.

Sehgal A.

Semin Surg Oncol. 1998 Jan-Feb;14(1):3-12. Review.

PMID:
9407626
2.

Molecular genetics of human glioma.

Westermark B, Nistér M.

Curr Opin Oncol. 1995 May;7(3):220-5. Review.

PMID:
7654823
3.

Alterations of the TP53 gene in human gliomas.

Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH.

Cancer Res. 1994 Mar 1;54(5):1324-30.

4.

Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.

Leung SY, Yuen ST, Chan TL, Chan AS, Ho JW, Kwan K, Fan YW, Hung KN, Chung LP, Wyllie AH.

Oncogene. 2000 Aug 17;19(35):4079-83.

5.

Oncogenes and glial tumors.

Watkins D, Rouleau GA.

Rev Neurol (Paris). 1992;148(6-7):402-7. Review.

PMID:
1448659
6.

[Mechanisms of molecular development of human glioma].

Schlegel U.

Nervenarzt. 1993 Aug;64(8):485-93. Review. German.

PMID:
8413746
7.

Epidemiology, cytogenetics, and molecular biology of brain tumors.

Kyritsis AP, Saya H.

Curr Opin Oncol. 1993 May;5(3):474-80. Review.

PMID:
8494908
8.

Genetic pathways of two types of gastric cancer.

Tahara E.

IARC Sci Publ. 2004;(157):327-49. Review.

PMID:
15055305
9.

Prognostic stratification of patients with anaplastic gliomas according to genetic profile.

Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M.

Cancer. 2006 Oct 15;107(8):1891-7.

10.

p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.

Jin W, Xu X, Yang T, Hua Z.

Chin Med J (Engl). 2000 Jul;113(7):662-6.

PMID:
11776043
11.

[Malignant gliomas. Oncogenic considerations].

Pérez-Ortiz L, Zaldívar-Vaillant T, Tamayo-Suárez JD.

Rev Neurol. 2000 Jul 1-15;31(1):49-52. Review. Spanish.

PMID:
10948584
12.

Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas.

Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, Heldin CH, Wiestler OD, Louis DN, von Deimling A, Nistér M.

Cancer Res. 1996 Jan 1;56(1):164-71.

13.

Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma.

Bigner SH, Vogelstein B.

Brain Pathol. 1990 Sep;1(1):12-8. Review.

PMID:
1669688
15.
16.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
20.

Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.

Kujas M, Lejeune J, Benouaich-Amiel A, Crinière E, Laigle-Donadey F, Marie Y, Mokhtari K, Polivka M, Bernier M, Chretien F, Couvelard A, Capelle L, Duffau H, Cornu P, Broët P, Thillet J, Carpentier AF, Sanson M, Hoang-Xuan K, Delattre JY.

Ann Neurol. 2005 Aug;58(2):322-6.

PMID:
16049942

Supplemental Content

Support Center